Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Presentation symbols : Fbio save search
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
Published: 2024-03-11 (Crawled : 12:30) - globenewswire.com
DERM | $3.45 -3.63% -3.77% 100K
|
|
| O: -1.45%
H: 0.88%
C: -0.88%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.48%
H: 2.87%
C: -4.31%
dfd-29 presentation corporation meeting impact medical trial
Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation at 65th American Society of Hematology (ASH) Annual Meeting
Published: 2023-11-02 (Crawled : 13:00) - globenewswire.com
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: -1.91%
H: 6.99%
C: 3.9%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -1.19%
H: 36.74%
C: 16.87%
mb-106 presentation meeting car-t
Checkpoint Therapeutics Announces Presentation of New Cosibelimab Pharmacokinetic Data Supporting Extended-Interval Dosing
Published: 2023-06-28 (Crawled : 12:00) - globenewswire.com
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.5%
H: 1.75%
C: -5.22%
CKPT | $1.47 -8.13% -8.84% 760K
|
Health Technology
|
| O: 0.43%
H: 3.16%
C: 0.85%
cosibelimab presentation therapeutics
Checkpoint Therapeutics Announces Presentation of Pivotal Trial Results of Cosibelimab at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2022-06-06 (Crawled : 21:00) - globenewswire.com
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -2.74%
H: 15.65%
C: 13.41%
CKPT | $1.47 -8.13% -8.84% 760K
|
Health Technology
|
| O: -2.26%
H: 10.0%
C: 5.38%
trial therapeutics presentation results cosibelimab
Mustang Bio Announces Results from Follicular Lymphoma Cohort of Ongoing Phase 1/2 Clinical Trial of MB-106, CD20-Targeted CAR T Therapy, Selected for Oral Presentation at European Hematology Association 2022 Hybrid Congress
Published: 2022-05-12 (Crawled : 15:00) - globenewswire.com
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: 2.35%
H: 16.92%
C: 0.8%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 0.61%
H: 5.2%
C: -0.99%
mb-106 ongoing trial presentation phase 1
Checkpoint Therapeutics Announces Data Presentation of Pivotal Trial Results of Cosibelimab to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2022-04-28 (Crawled : 20:00) - biospace.com/
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 2.86%
H: 13.89%
C: 5.56%
CKPT | $1.47 -8.13% -8.84% 760K
|
Health Technology
|
| O: 3.31%
H: 1.71%
C: 0.0%
trial therapeutics presentation results cosibelimab
Mustang Bio Announces City of Hope MB-105 Prostate Stem Cell Antigen CAR T Data Selected for Presentation at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium
Published: 2022-02-15 (Crawled : 14:00) - biospace.com/
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: 1.69%
H: 5.15%
C: 5.15%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 1.09%
H: 2.15%
C: 1.08%
mb-105 america symposium state presentation cel stem cell cancer
Mustang Bio Announces MB-106 CD20-Targeted CAR T Data Selected for Presentation at the 2022 Tandem Meetings I Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
Published: 2022-01-07 (Crawled : 21:00) - globenewswire.com
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
| Email alert
Add to watchlist
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
| Email alert
Add to watchlist
mb-106 ces presentation cel therapy
Mustang Bio Announces MB-106 CD20-Targeted CAR T Data Selected for Presentation at 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-11-04 (Crawled : 15:15) - globenewswire.com
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: -0.4%
H: 0.02%
C: -3.64%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.82%
H: 0.28%
C: -3.04%
presentation ema car-t
Caelum and Alexion Announce Upcoming CAEL-101 Data Presentations at the European Hematology Association Congress 2021
Published: 2021-05-12 (Crawled : 22:00) - biospace.com/
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.79%
H: 2.93%
C: -1.87%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.15%
H: 0.55%
C: -0.4%
presentation europe
Mustang Bio Announces MB-106 CD20-Targeted CAR T Data Selected for Presentation at European Hematology Association 2021 Virtual Congress
Published: 2021-05-12 (Crawled : 17:00) - globenewswire.com
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: -0.34%
H: 6.48%
C: -2.05%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.79%
H: 2.93%
C: -1.87%
presentation europe car-t
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.